TY - JOUR
T1 - Patients with autism spectrum disorders display reproducible functional connectivity alterations
AU - Holiga, Štefan
AU - Hipp, Joerg F.
AU - Chatham, Christopher H.
AU - Garces, Pilar
AU - Spooren, Will
AU - D’Ardhuy, Xavier Liogier
AU - Bertolino, Alessandro
AU - Bouquet, Céline
AU - Buitelaar, Jan K.
AU - Bours, Carsten
AU - Rausch, Annika
AU - Oldehinkel, Marianne
AU - Bouvard, Manuel
AU - Amestoy, Anouck
AU - Caralp, Mireille
AU - Gueguen, Sonia
AU - Moal, Myriam Ly Le
AU - Houenou, Josselin
AU - Beckmann, Christian F.
AU - Loth, Eva
AU - Murphy, Declan
AU - Charman, Tony
AU - Tillmann, Julian
AU - Laidi, Charles
AU - Delorme, Richard
AU - Beggiato, Anita
AU - Gaman, Alexandru
AU - Scheid, Isabelle
AU - Leboyer, Marion
AU - d’Albis, Marc Antoine
AU - Sevigny, Jeff
AU - Czech, Christian
AU - Bolognani, Federico
AU - Honey, Garry D.
AU - Dukart, Juergen
PY - 2019/2/27
Y1 - 2019/2/27
N2 - Despite the high clinical burden, little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here, we addressed these questions in four large ASD cohorts. Using rs-fMRI, we identified functional connectivity alterations associated with ASD. We tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status, and clinical symptom severity. Our results showed reproducible patterns of ASD-associated functional hyper- and hypoconnectivity. Hypoconnectivity was primarily restricted to sensory-motor regions, whereas hyperconnectivity hubs were predominately located in prefrontal and parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the identified regions were shown to be a key driver of these abnormalities. This reproducible pathophysiological phenotype was partially associated with core ASD symptoms related to communication and daily living skills and was not affected by age, sex, or medication status. Although the large effect sizes in standardized cohorts are encouraging with respect to potential application as a treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy readout.
AB - Despite the high clinical burden, little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here, we addressed these questions in four large ASD cohorts. Using rs-fMRI, we identified functional connectivity alterations associated with ASD. We tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status, and clinical symptom severity. Our results showed reproducible patterns of ASD-associated functional hyper- and hypoconnectivity. Hypoconnectivity was primarily restricted to sensory-motor regions, whereas hyperconnectivity hubs were predominately located in prefrontal and parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the identified regions were shown to be a key driver of these abnormalities. This reproducible pathophysiological phenotype was partially associated with core ASD symptoms related to communication and daily living skills and was not affected by age, sex, or medication status. Although the large effect sizes in standardized cohorts are encouraging with respect to potential application as a treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy readout.
UR - http://www.scopus.com/inward/record.url?scp=85062345819&partnerID=8YFLogxK
U2 - 10.1126/scitranslmed.aat9223
DO - 10.1126/scitranslmed.aat9223
M3 - Article
C2 - 30814340
AN - SCOPUS:85062345819
SN - 1946-6234
VL - 11
JO - Science Translational Medicine
JF - Science Translational Medicine
IS - 481
M1 - eaat9223
ER -